Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Terumo Corporation - SIC # 2840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TRUMY
Over the counter
2840
www.terumo.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Terumo Corporation
Terumo (TSE:4543) Valuation Check After Strong 2026 Earnings And Sharp Share Price Rebound
- May 24th, 2026 11:07 pm
Why Terumo (TSE:4543) Is Up 24.5% After Stronger Full-Year Earnings Lift Profitability - And What's Next
- May 24th, 2026 6:17 pm
Oil, China Economic Reports Damp Asian Stock Markets
- May 18th, 2026 4:36 am
OrganOx Announces Appointment of Naoya Iwata as CEO & President
- May 14th, 2026 6:00 am
Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo
- May 13th, 2026 7:19 am
Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun
- Apr 23rd, 2026 4:08 am
Drug-Eluting Stents - Global Market Trends, Developments and Investment Opportunities 2026-2034
- Apr 20th, 2026 9:04 am
Terumo Corporation Joins the Healthcare Plastics Recycling Council
- Apr 15th, 2026 9:00 am
Caristo Diagnostics Appoints Stephen Deitsch as Chief Executive Officer
- Apr 14th, 2026 9:00 am
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
- Apr 1st, 2026 7:00 am
Did Terumo’s (TSE:4543) New Tata Elxsi Partnership and Bond Shelf Just Reframe Its Investment Narrative?
- Mar 30th, 2026 5:06 am
Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation
- Mar 19th, 2026 3:39 am
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
- Mar 12th, 2026 6:17 am
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Mar 9th, 2026 4:30 pm
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
- Mar 4th, 2026 7:10 pm
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
- Feb 19th, 2026 2:35 am
Terumo Record Q3 Highlights OrganOx Integration And Margin Story For Investors
- Feb 17th, 2026 8:21 am
Terumo Corp (TRUMF) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ...
- Feb 16th, 2026 6:03 pm
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
- Jan 6th, 2026 6:29 am
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation
- Dec 1st, 2025 7:00 am
Scroll